What is the role of immunofluorescence in diagnosing and managing IgA (Immunoglobulin A) nephropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Immunofluorescence in IgA Nephropathy Diagnosis and Management

Immunofluorescence is essential for the definitive diagnosis of IgA nephropathy, with mesangial dominant or co-dominant IgA deposits being the hallmark finding required to establish the diagnosis. 1

Diagnostic Role of Immunofluorescence

Primary Diagnostic Features

  • Mesangial IgA deposits: The defining characteristic that must be present for diagnosis
  • Standard immunofluorescence panel should include:
    • Immunoglobulins: IgA, IgG, IgM
    • Complement components: C3, C1q
    • Light chains: kappa and lambda 1

Specific Immunofluorescence Patterns

  1. IgA Subclass Analysis:

    • IgA1 is the predominant subclass found in glomerular deposits
    • Glomerular deposits are typically negative for IgA2
    • IgA1 is found in both mesangial and peripheral capillary areas 2
  2. Distribution Patterns:

    • Mesangial-only deposits: Most common pattern
    • Mesangial + glomerular capillary loop (GCL) deposits: Associated with:
      • Higher systolic blood pressure
      • Lower serum IgG levels
      • Heavier proteinuria 3
  3. Co-deposits:

    • IgG: When present, associated with:
      • Higher mesangial cellularity scores
      • More endocapillary proliferation
      • Trend toward poorer renal survival (HR 2.1,95% CI 1.0-4.6) 4
    • C1q: Deposition in both mesangial and GCL areas predicts poor renal prognosis 3
    • C3: Often present alongside IgA

Advanced Immunofluorescence Techniques

Protease Immunofluorescence

Recommended in specific scenarios:

  • When glomeruli are lacking in frozen tissue samples
  • In patients with monoclonal gammopathy with C3 glomerulonephritis or unclassified proliferative glomerulonephritis 5

Special Considerations

  • Recent research has revealed that even IgAN kidney biopsies without detectable IgG by routine immunofluorescence contain IgG autoantibodies specific for galactose-deficient IgA1 (Gd-IgA1) 6
  • These autoantibodies can be detected through specialized extraction techniques and confocal microscopy, supporting their pathogenic role 6

Clinical Correlation with Immunofluorescence Findings

Prognostic Implications

  • C1q deposition in both mesangial and GCL areas predicts poor renal outcomes 3
  • IgG deposits correlate with:
    • Higher mesangial cellularity
    • More endocapillary proliferation
    • Trend toward worse renal survival 4

Histopathologic Correlation

Immunofluorescence findings should be integrated with light microscopy findings using the MEST-C scoring system:

  • M: Mesangial hypercellularity
  • E: Endocapillary hypercellularity
  • S: Segmental glomerulosclerosis
  • T: Tubular atrophy/interstitial fibrosis
  • C: Crescents 1

Technical Considerations

Specimen Handling

  • Fresh frozen tissue is preferred for optimal immunofluorescence results
  • Paraffin-embedded tissue can be used after protease digestion, but may show different staining patterns:
    • Unfixed specimens show coarse granular or lumpy IgA deposits
    • Formalin-fixed specimens show fine granular and/or interrupted linear patterns 7

Pitfalls to Avoid

  1. False negatives: Can occur with improper tissue handling or fixation
  2. Inadequate sampling: At least two glomeruli should be examined
  3. Misinterpretation: IgG subclass restriction alone is not sufficient to establish monoclonality 5
  4. Overlooking co-deposits: Always evaluate for other immunoglobulins and complement components

Management Implications

While immunofluorescence is primarily diagnostic, certain patterns may influence management:

  • Patients with IgG or C1q co-deposits may warrant closer monitoring due to potential worse outcomes
  • The presence of capillary wall deposits and proliferative changes may influence treatment decisions
  • All patients should receive optimized supportive care with RAS blockade if proteinuria >0.5 g/day 1

In conclusion, immunofluorescence is not just diagnostic but provides valuable prognostic information in IgA nephropathy through detailed characterization of deposit composition and distribution.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.